CIS
AGIO icon

Capital International Sarl’s Agios Pharmaceuticals AGIO Stock Holding History

Capital International Sarl’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,198
Closed -$287K – 228
2020
Q3 		$287K Buy
8,198
+264
+3% +$11.6K 0.04% 200
2020
Q2 		$424K Buy
7,934
+1,594
+25% +$73.8K 0.06% 183
2020
Q1 		$225K Sell
6,340
-19,791
-76% -$915K 0.04% 177
2019
Q4 		$1.25M Buy
26,131
+3,931
+18% +$149K 0.19% 116
2019
Q3 		$719K Sell
22,200
-7,700
-26% -$319K 0.12% 131
2019
Q2 		$1.49M Hold
29,900
– – 0.21% 105
2019
Q1 		$2.02M Sell
29,900
-4,500
-13% -$262K 0.25% 99
2018
Q4 		$1.59M Hold
34,400
– – 0.19% 105
2018
Q3 		$2.65M Buy
34,400
+7,300
+27% +$587K 0.25% 97
2018
Q2 		$2.28M Hold
27,100
– – 0.23% 97
2018
Q1 		$2.22M Sell
27,100
-5,500
-17% -$425K 0.21% 98
2017
Q4 		$1.86M Sell
32,600
-98,200
-75% -$6.18M 0.17% 107
2017
Q3 		$8.73M Sell
130,800
-23,300
-15% -$1.4M 0.73% 43
2017
Q2 		$7.93M Buy
154,100
+1,000
+0.7% +$51.1K 0.68% 47
2017
Q1 		$8.94M Sell
153,100
-9,400
-6% -$451K 0.77% 36
2016
Q4 		$6.78M Buy
162,500
+15,100
+10% +$792K 0.62% 53
2016
Q3 		$7.79M Hold
147,400
– – 0.66% 48
2016
Q2 		$6.17M Buy
147,400
+30,700
+26% +$1.52M 0.53% 66
2016
Q1 		$4.74M Hold
116,700
– – 0.4% 76
2015
Q4 		$7.58M Buy
116,700
+35,400
+44% +$2.32M 0.64% 58
2015
Q3 		$5.74M Buy
81,300
+5,800
+8% +$567K 0.51% 63
2015
Q2 		$8.39M Sell
75,500
-11,200
-13% -$1.21M 0.62% 55
2015
Q1 		$8.18M Sell
86,700
-2,600
-3% -$291K 0.59% 60
2014
Q4 		$10M Buy
+89,300
New +$7.97M 0.62% 58

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Capital International Sarl's AGIO Position: Q4 2020 in Review

Capital International Sarl sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 8,198 shares — an estimated $287K sold.

Capital International Sarl first reported a position in AGIO in Q4 2014 and held it in 24 quarters. The position peaked at $10M in Q4 2014. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Capital International Sarl reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Capital International Sarl sold 8,198 Agios Pharmaceuticals shares in Q4 2020, an estimated $287K.
  • Capital International Sarl first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Capital International Sarl's Agios Pharmaceuticals position peaked at $10M in Q4 2014.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Capital International Sarl's 13F filing for Q4 2020, filed 16 Feb 2021.